17031479|t|Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects.
17031479|a|Our aim was to determine changes in free amino acid (FAA) and dipeptide (DP) concentrations in probable Alzheimer's disease (pAD) subjects compared with control (CT) subjects using liquid chromatography and electrospray ionization tandem mass spectrometry (LCMS2). We recruited gender- and age-matched study participants based on neurological and neuropsychological assessments. We measured FAAs and DPs in cerebrospinal fluid (CSF), plasma and urine using LCMS2 with selected reaction monitoring (SRM). Imidazole-containing FAAs (histidine, methyl-histidine), catecholamines (L-DOPA and dopamine), citrulline, ornithine, glycine and antioxidant DPs (carnosine and anserine) accounted for the major changes between CT and pAD. Carnosine levels were significantly lower in pAD (328.4 +/- 91.31 nmol/dl) than in CT plasma (654.23 +/- 100.61 nmol/dl). In contrast, L-DOPA levels were higher in pAD (1400.84 +/- 253.68) than CT (513.10 +/- 121.61 nmol/dl) plasma. These data underscore the importance of FAA and DP metabolism in the pathogenesis of AD. Since our data show changes in antioxidants, neurotransmitters and their precursors, or FAA associated with urea metabolism in pAD compared with CT, we propose that manipulation of these metabolic pathways may be important in preventing AD progression.
17031479	20	29	dipeptide	Chemical	MESH:D004151
17031479	62	81	Alzheimer's disease	Disease	MESH:D000544
17031479	145	148	FAA	Chemical	-
17031479	154	163	dipeptide	Chemical	MESH:D004151
17031479	165	167	DP	Chemical	MESH:D004151
17031479	196	215	Alzheimer's disease	Disease	MESH:D000544
17031479	217	220	pAD	Disease	MESH:D000544
17031479	483	487	FAAs	Chemical	MESH:C049328
17031479	492	495	DPs	Chemical	MESH:D004176
17031479	596	605	Imidazole	Chemical	MESH:C029899
17031479	617	621	FAAs	Chemical	MESH:C049328
17031479	623	632	histidine	Chemical	MESH:D006639
17031479	634	650	methyl-histidine	Chemical	MESH:D008762
17031479	653	667	catecholamines	Chemical	MESH:D002395
17031479	669	675	L-DOPA	Chemical	MESH:D007980
17031479	680	688	dopamine	Chemical	MESH:D004298
17031479	691	701	citrulline	Chemical	MESH:D002956
17031479	703	712	ornithine	Chemical	MESH:D009952
17031479	714	721	glycine	Chemical	MESH:D005998
17031479	738	741	DPs	Chemical	MESH:D004176
17031479	757	765	anserine	Chemical	MESH:D000861
17031479	814	817	pAD	Disease	MESH:D000544
17031479	864	867	pAD	Disease	MESH:D000544
17031479	954	960	L-DOPA	Chemical	MESH:D007980
17031479	983	986	pAD	Disease	MESH:D000544
17031479	1092	1095	FAA	Chemical	-
17031479	1100	1102	DP	Chemical	MESH:D004151
17031479	1137	1139	AD	Disease	MESH:D000544
17031479	1229	1232	FAA	Chemical	-
17031479	1249	1253	urea	Chemical	MESH:D014508
17031479	1268	1271	pAD	Disease	MESH:D000544
17031479	1378	1380	AD	Disease	MESH:D000544
17031479	Association	MESH:D014508	MESH:D000544
17031479	Association	MESH:D006639	MESH:D000544
17031479	Association	MESH:D005998	MESH:D000544
17031479	Association	MESH:D008762	MESH:D000544
17031479	Association	MESH:D002395	MESH:D000544
17031479	Association	MESH:D004151	MESH:D000544
17031479	Association	MESH:D000861	MESH:D000544
17031479	Association	MESH:C029899	MESH:D000544
17031479	Association	MESH:D007980	MESH:D000544
17031479	Association	MESH:D004298	MESH:D000544
17031479	Association	MESH:C049328	MESH:D000544
17031479	Association	MESH:D002956	MESH:D000544
17031479	Association	MESH:D009952	MESH:D000544
17031479	Association	MESH:D004176	MESH:D000544

